Morristown, NJ4 Active Studies

Leukemia Clinical Trials in Morristown, NJ

Find 4 actively recruiting leukemia clinical trials in Morristown, NJ. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,918
Enrolling

Recruiting Leukemia Studies in Morristown

RecruitingMorristown, NJNCT06345729

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...

600 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingMorristown, NJNCT06074588

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

The purpose of this study is to evaluate sacituzumab tirumotecan versus chemotherapy (docetaxel or pemetrexed) for the treatment of previously-treated non-small cell lung cancer (NSCLC) with exon 19de...

556 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingMorristown, NJNCT06117774

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS)....

400 participants
Amgen
View Study Details
RecruitingMorristown, NJNCT04988555

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in adult patients with acute leukemia....

362 participants
Sumitomo Pharma America, Inc.
View Study Details

About Leukemia Clinical Trials in Morristown

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Morristown, NJ. These studies are seeking a combined 1,918 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Amgen, Sumitomo Pharma America, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Morristown — FAQ

Are there leukemia clinical trials in Morristown?

Yes, there are 4 leukemia clinical trials currently recruiting in Morristown, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Morristown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Morristown research site will contact you about next steps.

Are clinical trials in Morristown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Morristown studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Morristown are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov